Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2023-02-17 00:00:00 ET · period of report 2023-02-15 · accession 0001415889-23-002714 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-17 | 2023-02-15 | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | +3,386 | 146.9K | +2% | $0 |
| D | 2023-02-17 | 2023-02-15 | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | F - Tax | $49.20 | -1,170 | 145.7K | -0.8% | -$57.6K |
| D | 2023-02-17 | 2023-02-15 | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $48.39 | -10.0K | 143.5K | -7% | -$483.9K |
| D | 2023-02-17 | 2023-02-15 | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | -3,386 | 6,772 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-15 | M | A | 3,386 | $0.00 | 146,863 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-15 | F | D | 1,170 | $49.20 | 145,693 | D | — | — | (F2) The reported disposition of 1,170 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 3 | Common | Common Stock | 2023-02-15 | S | D | 10,000 | $48.39 | 143,477 | D | — | — | |
| 4 | Derivative | Restricted Stock Units | 2023-02-15 | M | D | 3,386 | $0.00 | 6,772 | D | $0.00 · — to — | 3,386 Common Stock | (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |